Pembrolizumab for previously treated advanced anal squamous cell carcinoma: Pooled results from the KEYNOTE-028 and KEYNOTE-158 studies.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aurelien Marabelle, Philippe Alexandre Cassier, Marwan Fakih, Steven Chuan-Hao Kao, Dorte Nielsen, Antoine Italiano, Tormod Guren, Marloes Van Dongen, Kristen Renee Spencer, Giovanni M. Bariani, Paolo Antonio Ascierto, Armando Santoro, Sandrine Hiret, Patrick Alexander Ott, Sarina Anne Piha-Paul, Chih-Chin Liu, Melanie A. Leiby, Kevin Norwood, Jean-Pierre Delord
Institutions: Université Paris-Saclay, Institut Gustave Roussy, Centre Léon Bérard, City Of Hope National Medical Center, Chris O’Brien Lifehouse, University of Copenhagen, Herlev Hospital, Institut Bergonié, Oslo University Hospital, The Netherlands Cancer Institute, Rutgers Cancer Institute, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Humanitas University, Institut de Cancérologie de l'Ouest, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3029930204